Completed PhD projects

Year of completion



Career path


Joy (Sirihathai) Srikwanjai

Synthesis of Novel Amides and Related Compounds with Applications in Medicinal Chemistry

Joy will be returning to Thailand after completing her PhD


Sergi Ortoll 

Synthesis of Heterocyclic Scaffolds Using Reagentless Techniques

Sergi worked as a Post Doctoral Research Fellow in SDDC and returned to Spain in July 2023


Gareth Williams

Identification and characterisation of novel inhibitors of polynucleotide kinase 3’-phosphatase

Gareth is working with BenevolentAI (Cambridge, UK)


Fiona Scott

Development of PKN2 chemical probes to enable drug discovery

Fiona is a medical writer


James Noble

The biological and pharmacological allosteric modulation of inositol monophosphatase

James is working as  Research Fellow at the UK Dementia Research Institute, King’s College


Scott Henderson

Design, synthesis and characterisation of tool compounds to define the roles of serine racemase and dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) in diseases of the central nervous system

Scott is working in the United States of America


Yusuf Ali

Design, synthesis and characterization of tool inhibitors targeting BLM helicase



Victoria Miller

Identification of potent and selective inhibitors of the epithelial sodium channel (ENaC) delta

Victoria is training as a patent attorney


Lucas Kraft

Therapeutic approaches to ApoE



Ryan West

The design and synthesis of drug-like trypanosome alternative oxidase inhibitors for the treatment of African trypanosomiasis

Ryan is a Senior Scientific Officer at the CRUK Beatson Institute in Glasgow


Tina (Xiangrong Chen)

Discovering inhibitors of human Bloom syndrome protein (BLM)

Tina works as a Research Fellow at the Genome Damage and Stability Centre, University of Sussex


Chloe Koulouris

Identification and characterisation of a novel inhibitor of serine racemase through a fragment-based drug discovery strategy

Chloe works as Research Fellow at the Genome Damage and Stability Centre, University of Sussex


Thalia Carreno Velazquez

Structure-based drug discovery approaches to identify modulators of the Nrf2 pathway and glutamate receptors AMPA GluA2 and kainate GluK1 and GluK2

Thalia works as Scientific Technician at Allergy Therapeutics


Michael Paradowski

Spirooxindoles derivatives as novel inhibitors of the respiratory syncytial virus

Michael works as a Research Fellow at Cardiff University


Tom Moore

Synthetic strategies towards challenging PPI drug targets



Katie Duffell

Design and characterisation of tool inhibitors of DNA damage response proteins

Katie is account director at Instinctif partners